153 related articles for article (PubMed ID: 12535865)
1. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester retards vascular sprouting in angiogenesis.
Kon K; Fujii S; Kosaka H; Fujiwara T
Microvasc Res; 2003 Jan; 65(1):2-8. PubMed ID: 12535865
[TBL] [Abstract][Full Text] [Related]
2. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway.
Xiong M; Elson G; Legarda D; Leibovich SJ
Am J Pathol; 1998 Aug; 153(2):587-98. PubMed ID: 9708818
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells.
Dulak J; Józkowicz A; Dembinska-Kiec A; Guevara I; Zdzienicka A; Zmudzinska-Grochot D; Florek I; Wójtowicz A; Szuba A; Cooke JP
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):659-66. PubMed ID: 10712388
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise.
Gavin TP; Spector DA; Wagner H; Breen EC; Wagner PD
J Appl Physiol (1985); 2000 Apr; 88(4):1192-8. PubMed ID: 10749807
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin.
Fujii E; Irie K; Ohba K; Ogawa A; Yoshioka T; Yamakawa M; Muraki T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):475-80. PubMed ID: 9349634
[TBL] [Abstract][Full Text] [Related]
6. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
Fukumura D; Gohongi T; Kadambi A; Izumi Y; Ang J; Yun CO; Buerk DG; Huang PL; Jain RK
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2604-9. PubMed ID: 11226286
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide mediates ultrasound-induced hypoxia-inducible factor-1alpha activation and vascular endothelial growth factor-A expression in human osteoblasts.
Wang FS; Kuo YR; Wang CJ; Yang KD; Chang PR; Huang YT; Huang HC; Sun YC; Yang YJ; Chen YJ
Bone; 2004 Jul; 35(1):114-23. PubMed ID: 15207747
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of the exercise-induced increase in skeletal muscle Flt-1 mRNA by nitric oxide synthase inhibition.
Gavin TP; Wagner PD
Acta Physiol Scand; 2002 Jul; 175(3):201-9. PubMed ID: 12100359
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival.
Kane AJ; Barker JE; Mitchell GM; Theile DR; Romero R; Messina A; Wagh M; Fraulin FO; Morrison WA; Stewart AG
Br J Pharmacol; 2001 Apr; 132(8):1631-8. PubMed ID: 11309233
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.
Ziche M; Morbidelli L; Choudhuri R; Zhang HT; Donnini S; Granger HJ; Bicknell R
J Clin Invest; 1997 Jun; 99(11):2625-34. PubMed ID: 9169492
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
[TBL] [Abstract][Full Text] [Related]
12. Constitutively synthesized nitric oxide is a physiological negative regulator of mammalian angiogenesis mediated by basic fibroblast growth factor.
Norrby K
Int J Exp Pathol; 2000 Dec; 81(6):423-7. PubMed ID: 11298189
[TBL] [Abstract][Full Text] [Related]
13. A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse model.
Uneda S; Hata H; Matsuno F; Nagasaki A; Harada N; Mitsuya Y; Matsuzaki H; Mitsuya H
Br J Haematol; 2003 Feb; 120(3):396-404. PubMed ID: 12580953
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
[TBL] [Abstract][Full Text] [Related]
15. Significance of nitric oxide and peroxynitrite in permeability changes of the retinal microvascular endothelial cell monolayer induced by vascular endothelial growth factor.
Marumo T; Noll T; Schini-Kerth VB; Harley EA; Duhault J; Piper HM; Busse R
J Vasc Res; 1999; 36(6):510-5. PubMed ID: 10629427
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal expression of vascular endothelial growth factor and nitric oxide synthase by coronary arterial wall cells during chronic inhibition of nitric oxide synthesis in rats.
Sakamoto H; Nakamura T; Akuzawa N; Masuda H; Sumino H; Saito Y; Ohyama Y; Kurashina T; Tamura J; Kurabayashi M
Nephron; 2002 Oct; 92(2):472-4. PubMed ID: 12218334
[TBL] [Abstract][Full Text] [Related]
17. Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer.
Emanueli C; Salis MB; Van Linthout S; Meloni M; Desortes E; Silvestre JS; Clergue M; Figueroa CD; Gadau S; Condorelli G; Madeddu P
Circulation; 2004 Sep; 110(12):1638-44. PubMed ID: 15364809
[TBL] [Abstract][Full Text] [Related]
18. VEGF(121)- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production.
Yang HT; Yan Z; Abraham JA; Terjung RL
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1097-104. PubMed ID: 11179052
[TBL] [Abstract][Full Text] [Related]
19. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.
El-Remessy AB; Behzadian MA; Abou-Mohamed G; Franklin T; Caldwell RW; Caldwell RB
Am J Pathol; 2003 Jun; 162(6):1995-2004. PubMed ID: 12759255
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors.
Jadeski LC; Lala PK
Am J Pathol; 1999 Oct; 155(4):1381-90. PubMed ID: 10514420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
